Explore resources from the 340B Advocacy Initiative and others.
A 340B Vendor Draws Scrutiny from U.S. Senate
March 11, 2026
A U.S. Senate investigation notes that Apexus appears to have expanded its business beyond its core role as a vendor, working with covered entities to increase 340B utilization and creating additional business lines to increase its own profits.
Emergency legislation would create acquisition loophole for UConn Health
February 26, 2026
The proposal would fast-track UConn Health’s planned acquisition of the Albert J. Solnit Children’s Center South campus, currently run by the state Department of Children and Families. The deal would ensure that UConn Health is treating enough low-income patients to qualify for 340B drug pricing by the June 30 deadline.
Commentary: Stop abuse of federal program to lower drug prices
January 31, 2026
Working families are feeling the squeeze. Health care costs keep climbing; wages aren’t keeping pace; and union health plans are under growing pressure to do more with less. That’s why it’s worth taking a hard look at the federal 340B drug discount program.
Letter to the editor: The 340B program is out of control
January 26, 2026
One problem with a sprawling federal government is that programs can grow out of control without attracting much notice from regulators or the public. The 340B Drug Pricing Program is a prime example. Originally intended to provide low-cost medicines to needy patients, 340B has morphed into an $81 billion profit engine for large hospital systems, pharmacy chains and pharmacy benefit managers, with little evidence that savings reach patients.
Senators Agree: 340B Is Broken and Must Be Reformed
October 29, 2025
An October hearing held by the U.S. Senate HELP Committee delivered bipartisan calls for both preservation and reform. At first glance, those two goals may seem at odds with each other. But when it comes to 340B, reform may be what’s needed to preserve the program for the future.
Rep. La Shawn K. Ford: Stop letting Chicago’s hospital aid flow to wealthy suburbs
October 24, 2025
"Unfortunately, hospitals in Illinois are seriously abusing the 340B program...This intentional exploitation of the program leaves the very communities the program was designed to help even further behind."
Growth in the 340B Drug Pricing Program
September 9, 2025
The CBO examines drug purchases made through the 340B program in 2021, growth in such purchases from 2010 to 2021, and factors that contributed to that growth. CBO also assesses how the 340B program affects the federal budget.
Congress Must Act to Bring Needed Reforms to the 340B Drug Pricing Program
April 30, 2025
A report published in April 2025 by the Senate Committee on Health, Education, Labor & Pensions details Chairman Cassidy's investigation into the 340B program, its challenges and the need for reform.